321A — Human Stage Holdings Income Statement
0.000.00%
Last trade - 00:00IndustrialsHighly SpeculativeMicro Cap
Annual income statement for Human Stage Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2024 March 31st | 2025 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | Tanshin |
| Standards: | JAS | — |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 4,405 | 4,055 |
| Cost of Revenue | ||
| Gross Profit | 786 | 688 |
| Selling / General / Administrative Expenses | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 4,400 | 4,102 |
| Operating Profit | 5.08 | -47.6 |
| Gain / Loss on Sale of Assets | ||
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | 239 | 65.1 |
| Provision for Income Taxes | ||
| Net Income After Taxes | 151 | 47.2 |
| Net Income Before Extraordinary Items | ||
| Net Income | 151 | 47.2 |
| Adjustments to Net Income | ||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | 151 | 47.2 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 119 | 37.3 |
| Dividends per Share |